Search by Drug Name or NDC

NDC 70934-0211-96 Carvedilol 12.5 mg/1 Details

Carvedilol 12.5 mg/1

Carvedilol is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is CARVEDILOL.

MedlinePlus Drug Summary

Carvedilol is used to treat heart failure (condition in which the heart cannot pump enough blood to all parts of the body) and high blood pressure. It also is used to treat people who have had a heart attack. Carvedilol is often used in combination with other medications. Carvedilol is in a class of medications called beta-blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 70934-0211-96
Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Carvedilol

Product Information

NDC	70934-0211
Product ID	70934-211_b815d39a-6509-56a1-e053-2a95a90a4b08
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Carvedilol
Proprietary Name Suffix	n/a
Non-Proprietary Name	Carvedilol
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	12.5
Active Ingredient Units	mg/1
Substance Name	CARVEDILOL
Labeler Name	Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Pharmaceutical Class	Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077614
Listing Certified Through	2022-12-31

Package

NDC 70934-0211-96 (70934021196)

Pricing Information	N/A
NDC Package Code	70934-211-96
Billing NDC	70934021196
Package	180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-211-96)
Marketing Start Date	2021-12-02
NDC Exclude Flag	N